Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Juergen Wolf, Tobias R. Overbeck, Ji-Youn Han, Maximilian Hochmair, Filippo de Marinis, Kadoaki Ohashi, Egbert F. Smit, Danielle Power, Edward B. Garon, Harry J. M. Groen, Daniel Shao-Weng Tan, Maeve Waldron-Lynch, Sylvie Le Mouhaer, Ngozi Nwana, Monica Giovannini, Rebecca Suk Heist

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20-May-2020

Cite this